TipRanks
Go Ultimate55% OFF

Eagle Pharmaceuticals (EGRX) Cash flow

Eagle Pharmaceuticals Cash Flow

EGRX's free cash flow for Q2 2023 was $-132.00K. For the 2023 fiscal year, EGRX's free cash flow was decreased by $-6.00K and operating cash flow was $-126.00K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 22Dec 21Dec 20Dec 19Dec 18
$ 50.70M$ 28.22M$ 49.50M$ 55.99M$ 52.38M
$ -86.83M$ -5.32M$ -18.25M$ -777.00K$ -133.00K
$ -6.21M$ -28.39M$ -37.87M$ -24.23M$ -88.12M
$ 55.32M$ 97.66M$ 103.16M$ 109.78M$ 78.79M
$ 50.52M$ 27.90M$ 48.75M$ 55.21M$ 52.25M

Currency in USD

Eagle Pharmaceuticals Cash Flow

-100M-50M050M100M201720182019202020212022OperatingInvestingFinancing